Cholestasis and Behavioral Disorders
Gastroenterology and Hepatology from Bed to Bench,
,
8 March 2021
https://doi.org/10.22037/ghfbb.v14i2.1971
Abstract
Background: Memory and learning processes occur in different areas of the brain, especially the hippocampus and amygdala. Considering the expanded use of nanoparticles in recent years, it is important to understand the biological interactions of these materials. Alumina Nanoparticles are used in the provision of some vaccines, drug delivery, water purification and welding industry. Consequently, the potential effects of this substance on the cells and biochemical molecules should be investigated. Materials and Methods: Wistar male rats were divided into three groups; The control group, the sham group (received deionized water) and the test group (received Alumina Nanoparticles in the CA1 region at the dose of 0.37 mg / kg. The shuttle box was used to test the memory. Then the hippocampus of the rats was removed and used for histological examination with the method Haematoxylin & Eosin and tunel tests. Results: The results of the behavioral test showed a significant increase in latency of the experimental group in the dark room compared to the other two groups. Histological examination indicated a reduction in neuronal density, tissue necrosis (hematoxylin-eosin test) and apoptosis (tunel test) in CA1 region in the test group. Conclusion: The results show that Alumina Nanoparticles can be effective in neuronal degeneration and decrease memory and learning ability.
- Acute liver failure
- Cognitive impairments
- Neurotransmitter systems
References
Betterton, R.T., Broad, L.M., Tsaneva‐Atanasova, K. & Mellor, J.R. (2017) Acetylcholine modulates gamma frequency oscillations in the hippocampus by activation of muscarinic M1 receptors. Eur. J. Neurosci., 45, 1570–1585.
Faust, T.W., Assous, M., Shah, F., Tepper, J.M. & Koós, T. (2015) Novel fast adapting interneurons mediate cholinergic‐induced fast GABAA inhibitory postsynaptic currents in striatal spiny neurons. Eur. J. Neurosci., 42, 1764–1774.
Arnt, J., Bøgesø, K.P., Hyttel, J. & Meier, E. (1988a) Relative dopamine D1 and D2 receptor affinity and efficacy determine whether dopamine agonists induce hyperactivity or oral stereotypy in rats. Pharmacol. Toxicol., 62, 121–130.
Arnt, J., Hyttel, J. & Meier, E. (1988b) Inactivation of dopamine D-1 or D-2 receptors differentially inhibits stereotypies induced by dopamine agonists in rats. Eur. J. Pharmacol., 155, 37–47.
Aronson, D.C., Chamuleau, R.A., Frederiks, W.M., Gooszen, H.G., Heijmans, H.S. & James, J. (1993) Reversibility of cholestatic changes following experimental common bile duct obstruction: fact or fantasy. J. Hepatol., 18, 85–95.
Azami, N.S., Piri, M., Oryan, S., Jahanshahi, M., Babapour, V. & Zarrindast, M.R. (2010) Involvement of dorsal hippocampal alpha-adrenergic receptors in the effect of scopolamine on memory retrieval in inhibitory avoidance task. Neurobiol. Learn .Mem., 93, 455–62.
Bals-Kubik, R., Herz, A. & Shippenberg, T.S. (1989) Evidence that the aversive effects of opioid antagonists and kappa-agonists are centrally mediated. Psychopharmacology., 98, 203–206
Barros, R.C., Branco, L.G. & Carnio, E.C. (2004) Evidence for thermoregulation by dopamine D1 and D2 receptors in the anteroventral preoptic region during normoxia and hypoxia. Brain. Res., 1030, 165–171.
Bartus, R.T., Dean, R.L., Beer, B. & Lippa, A.S., (1982) The cholinergic hypothesis of geriatric memory dysfunction. Science., 217, 408–14.
Bearn, J. & Wessely, S. (1994) Neurobiological aspects of the chronic fatigue syndrome. Eur. J. Clin. Invest., 24, 79-90.
Bergasa, N.V., Rothman, R.B., Vergalla, J., Xu, H., Swain, M.G. & Jones, E.A. (1992) Central mu-opioid receptors are down-regulated in a rat model of cholestasis. J. Hepatol., 15, 220–224.
Bergasa, N.V., Alling, D.W., Vergalla, J. & Jones, E.A. (1994) Cholestasis in the male rat is associated with naloxone-reversible antinociception. J. Hepatol., 20, 85–90.
Bergasa, N.V., Sabol, S.L., Young 3rd, W.S., Kleiner, D.E. & Jones, E.A., (1995) Cholestasis is associated with preproenkephalin mRNA expression in the adult rat liver. Am. J. Physiol., 268, 346–354.
Bergasa. N.V., Zhou. J., Ravi, J. & Shi, Q. (1999) The opioid peptide analogD-Ala2-Met-enkephalinamide decreases bile flow by a central mechanism. Peptides., 20, 979–986.
Burak, K.W. & Le, T. (2002) Swain, MG. Increased sensitivity to the locomotor-activating effects of corticotropin-releasing hormone in cholestatic rats. Gastroenterology., 122(3), 681-8.
Calabrese, E.J. (2001) Dopamine: biphasic dose responses. Crit. Rev. Toxicol., 31, 563–583.
Cox, B. & Lee, T.F. (1977) Location of receptors mediating hypothermia after injection of dopamine agonists in rats [proceedings]. Br. J. Pharmacol., 59, 467–468.
Dilts, R.P. & Kalivas, P.W. (1990) Autoradiographic localization of delta opioid receptors within the mesocorticolimbic dopamine system using radioiodinated [2-D-penicillamine, 5-D-penicillamine] encephalin (125I-DPDPE). Synapse., 6,121–132.
Ebrahimi-ghiri, M., Nasehi, M., Rostami, P., Mohseni-Kouchesfehani, H. & Zarrindast, M.R. (2012) The effect of cholestasis on rewarding and exploratory behaviors induced by opioidergic and dopaminergic agents in mice. Arch. Iran. Med., 15(10), 617-24.
Eidi, M., Zarrindast, M.R., Eidi, A., Oryan, S. & Parivar. K. (2003) Effects of histamine and cholinergic systems on memory retention of passive avoidance learning in rats. Eur. J. Pharmacol., 465, 91–6.
Eslimi, D., Oryan, S., Nasehi, M. & Zarrindast MR. (2011) Effects of opioidergic systems upon anxiolytic-like behaviors induced in cholestatic rats. Eur. J. Pharmacol., 16, 670(1):180-5.
Eslimi Esfahani, D., Oryan, S., Nabiuni, m. & Karimian Peiro, M. (2017) The role of cholestasis in brain hippocampus trauma in male Wistar rat. Nova. Biologica. Reperta., 4(2), 128-136.
Gharoony, F., Oryan, S., Nabiuni, m., Eslimi Esfahani, D., Hosseinynia, T.S., Karimian Peiro, M. & Parsa, S. (2015) The histopathological effects of cholestasis on hypothalamic paraventricular and supraoptic nucleus on male wistar rats. Nova. Biologica. Reperta., 1 (2), 77-85.
Felipo, V. & Butterworth, R.F. (2002) Neurobiology of ammonia. Prog. Neurobiol., 67, 259–279.
Ferenci, p. (2017) Hepatic encephalopathy. Gastroenterol. Rep. (Oxf)., 5(2), 138–147.
Fibiger, H.C. (1991) Cholinergic mechanisms in learning, memory and dementia: a review of recent evidence. Trends. Neurosci., 14, 220–3.
Forton, D.M., Patel, N., Prince, M., Oatridge, A., Hamilton, G., Goldblatt, J., Allsop, J.M., Hajnal, J.V., Thomas, H.C., Bassendine, M., Jones, D.E. & Taylor-Robinson, S.D. (2004) Fatigue and primary biliary cirrhosis: association of globus pallidus magnetisation transfer ratio measurements with fatigue severity and blood manganese levels. Gut., 53(4):587-92.
Garcia, A.M., Martinez, R., Brandao, M.L. & Morato, S. (2005) Effects of apomorphine on rat behavior in the elevated plus-maze. Physiol. Behav., 85, 440–447.
Garcia-Ayllon, M.S., Silveyra, M.X., Candela, A., Compan, A., Claria, J. & Jover, R. (2006) Changes in liver and plasma acetylcholinesterase in rats with cirrhosis induced by bile duct ligation. Hepatology., 43, 444–53.
Glaser, S., Alvaro, D., Roskams, T., Phinizy, J.L., Stoica, G., Francis, H., Ueno, Y., Barbaro, B., Marzioni, M., Mauldin, J., Rashid, S., Mancino, M.G., LeSage, G. & Alpini, G. (2003) Dopaminergic inhibition of secretin-stimulated choleresis by increased PKC-gamma expression and decrease of PKA activity. Am. J. Physiol. Gastrointest. Liver Physiol., 284, 683–694.
Gyertyan, I. & Gal, K. (2003) Dopamine D3 receptor ligands show place conditioning effect but do not in_uence cocaine-induced place preference. Neuroreport., 14, 93 – 98.
Hasegawa, H., Meeusen, R., Sarre, S., Diltoer., M, Piacentini, M.F. & Michotte, Y. (2005) Acute dopamine/norepinephrine reuptake inhibition increases brain and core temperature in rats. J. Appl. Physiol., 99, 1397–1401
Hosseini, N., Nasehi, M., Radahmadi, M., & Zarrindast MR. (2013) Effects of CA1 glutamatergic systems upon memory impairments in cholestatic rats. Behav. Brain. Res., 256, 636-45.
Huerta, P.T. & Lisman, J.E. (1993) Heightened synaptic plasticity of hippocampal CA1 neurons during a cholinergically induced rhythmic state. Nature., 364, 723–5.
Huang, L.T., Chen, C.C., Sheen, J.M., Chen, Y.J., Hsieh, C.S. & Tain, Y.L. (2010) The interaction between high ammonia diet and bile duct ligation in developing rats: Assessment by spatial memory and asymmetric dimethylarginine. Int. J. Dev. Neurosci., 28, 169-74.
Imperato, A., Obinu, M.C., Casu, M.A., Mascia, M.S., Carta, G. & Gessa GL. (1996) Chronic morphine increases hippocampal acetylcholine release: possible relevance in drug dependence. Eur. J. Pharmacol., 302, 21–6.
Izquierdo, I. & Netto, C.A. (1990) Dual action of post-training naloxone on memory. Behav. Neural. Biol., 53, 140–146.
Hosseini, N., Alaei, H., Zarrindast, M.R., Nasehi, M. & Radahmadi, M. (2014) Cholestasis progression effects on long-term memory in bile duct ligation rats. Adv. Biomed. Res., 3, 215.
Haber, S.N. & Knutson, B. (2010) The reward circuit: linking primate anatomy and human imaging. Neuropsychopharmacology., 35, 4 – 26.
Houghoghi, V., Rezayof, A., Zyaian, S. & Zarrindast, M.R. (2009) Intradorsal hippocampal microinjection of lithium reverses morphine-induced impairment of memory in mice: interactions with dopamine receptor mechanism(s). Behav. Pharmacol., 20, 680–7.
Hoyer, D., Clarke, D.E., Fozard, J.R., Hartig, P.R., Martin, G.R., Mylecharane, E.J., Saxena, P.R. & Humphrey, P.P. (1994) International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). Pharmacol. Rev., 46, 157–203.
Javadi-Paydar, M., Ghiassy, B., Ebadian, S., Rahimi, N., Norouzi, A. & Dehpour, A.R. (2013) Nitric oxide mediates the beneficial effect of chronic naltrexone on cholestasis-induced memory impairment in male rats. Behav. Pharmacol., 24, 195-206.
Jover, R., Rodrigo, R., Felipo, V., Insausti, R., Saez-Valero, J. & García-Ayllón M. (2006) Brain edema and inflammatory activation in bile duct ligated rats with diet-induced hyperammonemia: A model of hepatic encephalopathy in cirrhosis. Hepatology., 43, 1257-66.
Kahveci, N., Gulec, G. & Ozluk, K. (2006) Effects of intracerebroventricularly-injected morphine on anxiety, memory retrieval and locomotor activity in rats: involvement of vasopressinergic system and nitric oxide pathway. Pharmacol. Biochem. Behav., 85, 859–867.
Khajehpour, L., Rezayof, A. & Zarrindast, M.R. (2008) Involvement of dorsal hippocampal nicotinic receptors in the effect of morphine on memory retrieval in passive avoidance task. Eur. J. Pharmacol., 584, 343–51.
Kirby, B.P. & Rawlins, J.N. (2003) The role of the septo-hippocampal cholinergic projection in T-maze rewarded alternation. Behav. Brain. Res., 143, 41–8.
Kountouras, J., Billing, B.H. & Scheuer, P.J. (1984) Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat. Br. J. Exp. Pathol., 65, 305–11.
Magen, I., Avraham, Y., Ackerman, Z., Vorobiev, L., Mechoulam, R. & Berry, E.M. (2009) Cannabidiol ameliorates cognitive and motor impairments in mice with bile duct ligation. J. Hepatol., 51, 528–534.
Magen, I., Avraham, Y., Ackerman, Z., Vorobiev, L., Mechoulam, R. & Berry, E.M. (2010) Cannabidiol ameliorates cognitive and motor impairments in bile-duct ligated mice via 5-HT1A receptor activation. Br. J. Pharmacol., 159(4), 950-7.
Mallajosyula, J.K., Kaur, D., Chinta, S.J., Rajagopalan, S., Rane, A., Nicholls, D.G., Di Monte, D.A., Macarthur, H. & Andersen, J.K., (2008) MAO-B elevation in mouse brain astrocytes results in Parkinson’s pathology. PLoS. One., 3, 1616.
Marquez-Aguirre, A.L., Canales-Aguirre, A.A., Gomez-Pinedo, U. & Galvez-Gastelum, F.J. (2010) Molecular aspects of hepatic encephalopathy. Neurologia., 25(4), 239-47.
Matsumoto, M., Weickert, C.S., Akil, M., Lipska, B.K., Hyde, T.M., Herman, M.M., Kleinman, J.E. & Weinberger, D.R. (2003) Catechol O-methyltransferase mRNA expression in human and rat brain: evidence for a role in cortical neuronal function. Neuroscience., 116, 127–137.
Mechoulam, R., Peters, M., Murillo-Rodriguez, E. & Hanus, L.O. (2007) Cannabidiol—recent advances. Chem. Biodivers., 4, 1678–1692.
Moezi, L., Shafaroodi, H., Sarkar, S., Emami-Razavi, S.H., Sanatkar, M., Mirazi, N. & Dehpour, A.R. (2006) Involvement of nitrergic and opioidergic systems in the hypothermia induced by cholestasis in rats. Pathophysiology., 13, 227–232.
Morrison, S.F. & Nakamura, K. (2011) Central neural pathways for thermoregulation. Front. Biosci., 16, 74–104.
Morris, R., Garrud, P., Rawlins, J., & O'Keefe, J., (1982) Place navigation impaired in rats of ethanol-induced gastric damage in cholestatic rats. Fundam Clin Pharmacol. 2001; 15: 181 – 187.
Narita, M., Matsushima, Y., Niikura, K., Takagi, S., Nakahara, K., Kurahashi, K., Abe, M., Saeki, M., Asato, M., Imai, S., Ikeda, K., Kuzumaki, N. & Suzuki, T., (2010) Implication of dopaminergic projection from the ventral tegmental area to the anterior cingulate cortex in mu-opioid-induced place preference. Addict. Biol., 15, 434–447.
Nasehi, M., Sahebgharani, M., Haeri-Rohani, A. & Zarrindast, M.R. (2009) Effects of cannabinoids infused into the dorsal hippocampus upon memory formation in 3-days apomorphine-treated rats. Neurobiol. Learn. Mem., 92, 391–399.
Nasehi, M., Mafi, F., Oryan, S., Nasri, S. & Zarrindast, M.R. (2011) The effects of dopaminergic drugs in the dorsal hippocampus of mice in the nicotine-induced anxiogenic-like response. Pharmacol. Biochem. Behav., 98, 468–473.
Nasehi, M., Amin Yavari, S. & Zarrindast, M.R. (2013a) Synergistic effects between CA1 mu opioid and dopamine D1-like receptors in impaired passive avoidance performance induced by hepatic encephalopathy in mice. Psychopharmacology (Berl)., 227(3), 553-66.
Nasehi, M., Ahmadzadeh, O., Rezayof, A. & Zarrindast, M.R. (2013b) Does CA1 dopaminergic system play a role in cholestasis induced hypothermia? Pathophysiology., 20(3), 181-9.
Nasehi, M., Tackallou, S.H., Hasani, I. & Nasehi, M. (2013d) Cholestasis impaired spatial and non-spatial novelty Nasehi M, Piri M, Abbolhasani K, Zarrindast MR. Involvement of opioidergic and nitrergic systems in memory acquisition and exploratory behaviors in cholestatic mice. Behav. Pharmacol., 24, 180-94.
Nicoll, J., Axiotis, C.A. & Bergasa, N.V. (2005) The delta opioid receptor 1 is expressed by proliferating bile ductules in rats with cholestasis: implications for the study of liver regeneration and malignant transformation of biliary epithelium. Med Hypotheses. 65, 1099 – 1105.
Nikolaus, S., Antke, C., Beu, M. & Muller, H.W., (2010) Cortical GABA, striatal dopamine and midbrain serotonin as the key players in compulsive and anxiety disorders– results from in vivo imaging studies. Rev. Neurosci., 21, 119–139.
Oryan, S.h., Nabiuni, M. & Eslimi Esfahani, D. (2017) Effects of Cholestasis on Aquaporin 4 Choroid Plexus of Male Wistar Rat. J. Animal. Researches., 30, 134-144.
Osaka, T. (2011) Hypoxia-induced hypothermia mediated by noradrenaline and nitric oxide in the rostromedial preoptic area. Neuroscience., 179, 170–178.
Pantiga, C., Rodrigo, L.R., Cuesta, M., Lopez, L. & Arias J.L. (2003) Cognitive defi cits in patients with hepatic cirrhosis and in liver transplant recipients. J. Neuropsychiatry. Clin. Neurosci., 15, 84-9.
Peregud, D.I., Vorontsova, O.N., Yakovlev, A.A., Panchenko, L.F. & Gulyaeva, N.V. (2008) Changes in anxiety in abstinence correlate with the state of the nigrostriatal system in the rat hippocampus. Neurosci. Behav. Physio., 38, 443–448.
Prado, V.F., Martins-Silva, C., de Castro, B.M., Lima, R.F., Barros, D.M. & Amaral, E. (2006) Mice deficient for the vesicular acetylcholine transporter are myasthenic and have deficits in object and social recognition. Neuron., 51, 601–12.
Radke, A.K., Rothwell, P.E., Gewirtz, J.C., 2011. An anatomical basis for opponent process mechanisms of opiate withdrawal. J. Neurosci. 31, 7533–7539.
Rao, V.L. Giguere, J.F., Laygurgues, G.P. & Buttreworth, R.F. (1993) Increased activities of MAOA and MAOB in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. Brain. Res., 621, 349–352.
Rezayof, A., Zarrindast, M.R., Sahraei, H. & Haeri-Rohani, A. (2003) Involvement of dopamine receptors of the dorsal hippocampus on the acquisition and expression of morphine-induced place preference in rats. J. Psychopharmacol., 17, 415–423.
Rezayof, A., Zatali, H., Haeri-Rohani, A. & Zarrindast, M.R. (2006) Dorsal hippocampal muscarinic and nicotinic receptors are involved in mediating morphine reward. Behav. Brain. Res. 166, 281–90.
Rezayof, A., Golhasani-Keshtan, F., Haeri-Rohani, A. & Zarrindast, M.R. (2007) Morphine-induced place preference: involvement of the central amygdala NMDA receptors. Brain. Res. 1133, 34 – 41.
Rezayof, A., Alijanpour, S., Zarrindast, M.R. & Rassouli, Y. (2008) Ethanol state-dependent memory: involvement of dorsal hippocampal muscarinic and nicotinic receptors. Neurobiol. Learn. Mem. 89, 441–7.
Rodriguez-Garay, E.A. (2003) Cholestasis: human disease and experimental animal models. Ann. Hepatol., 2(4), 150-8.
Roma, M.G., Crocenzi, F.A & Sanchez Pozzi, E.A. (2008) Hepatocellular transport in acquired cholestasis: new insights into functional, regulatory and therapeutic aspects. Clin. Sci. (Lond)., 114, 567–88.
Romero-Gomez, M., Cordoba, J., Jover, R., del Olmo, J.A., Ramirez, M. & Rey, R. (2007) Value of the critical flicker frequency in patients with minimal hepatic encephalopathy. Hepatology., 45, 879–85.
Sahraei, H., Etemadi, L., Rostami, P., Pourmotabbed, A., Zarrindast, M.R. & Shams, J. (2009) GABAB receptors within the ventral tegmental area are involved in the expression and acquisition of morphine-induced place preference in morphine-sensitized rats. Pharmaco.l Biochem. Behav. 91, 409 – 416.
Sasaki, K., Fan, L.W., Tien, L.T., Ma, T., Loh, H.H. & Ho, I.K. (2002) The interaction of morphine and gamma-aminobutyric acid (GABA)ergic systems in anxiolytic behavior: using mu-opioid receptor knockout mice. Brain. Res. Bull., 57, 689–694.
Schindler, C.W., Gormezano, I. & Harvey, J.A. (1987) Effects of morphine, ethylketocyclazocine, U-50,488H and naloxone on the acquisition of a classically conditioned response in the rabbit. J. Pharmacol. Exp. Ther., 243, 1010–1017
Sealfon, S.C. & Olanow, C.W. (2000) Dopamine receptors: from structure to behavior. Trends. Neurosci., 23, S34–40.
Tao, R. & Auerbach, S.B. (2002) Opioid receptor subtypes differentially modulate serotonin efflux in the rat central nervous system. J. Pharmacol. Exp. Ther., 303, 549–556.
Tarter, R.E., Arria, A.M., Carra, J. & Van Thiel, D.H. (1987) Memory impairments concomitant with nonalcoholic cirrhosis. Int. J. Neurosci., 32, 853-9.
Thornton, J.R. & Losowsky, M.S. (1988) Opioid peptides and primary biliary cirrhosis. BMJ., 297, 1501–1504.
Traynor, J. (2012) mu-Opioid receptors and regulators of G protein signaling (RGS) proteins: from a symposium on new concepts in mu-opioid pharmacology. Drug. Alcohol. Depend., 121, 173– 180.
Yurdaydin, C., Hortnagl, H., Steindl, P., Zimmermann, C., Pifl, C., Singer, E.A., Roth, E., Ferenci, P., 1990. Increased serotoninergic and noradrenergic activity in hepatic encephalopathy in rats with thioacetamide-induced acute liver failure. Hepatology 12, 695–700.
Vallone, D., Picetti, R. & Borrelli, E. (2000) Structure and function of dopamine receptors. Neurosci. Biobehav. Rev., 24, 125–132.
Weissenborn, K., Heidenreich, S., Giewekemeyer, K., Ruckert, N. & Hecker, H. (2003) Memory function in early hepatic encephalopathy. J. Hepatol., 39, 320–5.
Zarrindast, M.R. & Mousa-Ahmadi, E. (1999) Effects of GABAergic system on naloxone-induced jumping in morphine-dependent mice. Eur J Pharmacol. 381, 129 – 133.
Zarrindast, M.R., Bakhsha, A., Rostami, P. & Shafaghi, B. (2002a) Effects of intrahippocampal injection of GABAergic drugs on memory retention of passive avoidance learning in rats. J. Psychopharmacol., 16:313–9.
Zarrindast, M.R., Habibi, M., Borzabadi, S., Fazli-Tabaei, S., Hossein Yahyavi, S. & Rostamin, P. (2002b) The effects of dopamine receptor agents on naloxone-induced jumping behaviour in morphine-dependent mice. Eur. J. Pharmacol.; 451, 287 – 293.
Zarrindast, M.R. & Rezayof, A. (2004) Morphine state-dependent learning: sensitiza- tion and interactions with dopamine receptors. Eur. J. Pharmacol., 497, 197–204.
Zarrindast, M.R., Rostami, P., Zarei, M. & Roohbakhsh, A. (2005a) Intracerebroventricular effects of histaminergic agents on morphine-induced anxiolysis in the elevated plus-maze in rats. Basic. Clin. Pharmacol. Toxicol., 97, 276–281.
Zarrindast, M.R., Nasehi, M., Rostami, P., Rezayof, A & Fazli-Tabaei, S. (2005b) Repeated administration of dopaminergic agents in the dorsal hippocampus and morphine-induced place preference. Behav. Pharmacol., 16, 85–92.
Zarrindast, M.R., Bananej, M., Khalilzadeh, A., Fazli-Tabaei, S., Haeri-Rohani, A. & Rezayof, A. (2006) Influence of intracerebroventricular administration of dopaminergic drugs on morphine state-dependent memory in the step- down passive avoidance test. Neurobiol. Learn. Mem., 86, 286–292.
Zarrindast, M.R., Ebrahimi-Ghiri, M., Rostami, P. & Rezayof, A. (2007) Repeated pre-exposure to morphine into the ventral pallidum enhances morphine- induced place preference: involvement of dopaminergic and opioidergic mechanisms. Behav. Brain. Res., 181, 35 – 41.
Zarrindast, M.R., Babapoor-Farrokhran, S. & Rezayof, A. (2008a) Involvement of opioidergic system of the ventral hippocampus, the nucleus accumbens or the central amygdala in anxiety-related behavior. Life. Sci., 82, 1175–1181.
Zarrindast, M.R., Lahmi, A. & Ahamadi, S. (2008b) Possible involvement of mu-opioid receptors in effect of lithium on inhibitory avoidance response in mice. J. Psychopharmacol., 22, 865–871.
Zarrindast, M.R., Solati, J., Oryan, S. & Parivar, K. (2008c) Effect of intra-amygdala injection of nicotine and GABA receptor agents on anxiety-like behaviour in rats. Pharmacology., 82, 276–284.
Zarrindast, M.R., Dorrani, M., Lachinani, R. & Rezayof, A. (2010a) Blockade of dorsal hippocampal dopamine receptors inhibits state dependent learning induced by cannabinoid receptor agonist in mice. Neurosci. Res., 67, 25–32.
Zarrindast, M.R., Naghdi-Sedeh, N., Nasehi, M., Sahraei, H., Bahrami, F. & Asadi, F (2010b) The effects of dopaminergic drugs in the ventral hippocampus of rats in the nicotine-induced anxiogenic-like response.Neurosci. Lett., 475, 156–160.
Zarrindast, M.R., Navaeian, M. & Nasehi, M. (2010c) Influence of three-day morphine-treatment upon impairment of memory consolidation induced by cannabinoid infused into the dorsal hippocampus inrats. Neurosci. Res., 69:51–59.
Zarrindast, M.R., Navaeian, M. & Nasehi, M., (2011) Influence of three-day morphine treatment upon impairment of memory consolidation induced by cannabinoid infused into the dorsal hippocampus in rats. Neurosci. Res., 69, 51–59.
Zarrindast, M.R., Hoseindoost, S. & Nasehi, M. (2012a) Possible interaction between opioidergic and cholinergic systems of CA1 in cholestasis-induced amnesia in mice. Behav. Brain. Res., 1, 228(1):116-24.
Zarrindast, M.R., Khalifeh, S., Rezayof, A., Rostami, P., Aghamohammadi Sereshki, A. & Zahmatkesh, M. (2012b) Involvement of rat dopaminergic system of nucleus accumbens in nicotine-induced anxiogenic-like behaviors. Brain. Res., 1460, 25–32.
Zarrindast, M.R., Eslimi Esfahani, D., Oryan, S,. Nasehi, M. & Torabi Nami, M. (2013) Effects of dopamine receptor agonist and antagonists on cholestasis-induced anxiolytic-like behaviors in rats. Eur. J. Pharmacol., 702, (1-3):25-31.
Zeneroli, M.L., Baraldi, M., Ventura, E., Vezzelli, C., Tofanetti, O., Germini, M. & Casciarri, I. (1991) Alterations of GABA-A and dopamine D-2 brain receptors in dogs with portal-systemic encephalopathy. Life. Sci., 48, 37–50.
Zhang, H.T., Xu, Z.M., Luo, Z.P. & Qin, B.Y. (1996) Anxiogenic effect of naltrexone in social interaction test in rats. Zhongguo. Yao. Li. Xue. Bao., 17, 314–317.
Zhang, Y.T., Zheng, Q.S., Pan, J. & Zheng, R.L. (2004) Oxidative damage of biomole- cules in mouse liver induced by morphine and protected by antioxidants. Basic. Clin. Pharmacol. Toxicol., 95, 53–58.
Zimatkin, S.M., Baraban, O.V., Emel’yanchik & S.V. (2008) Metabolic changes in rat brain histaminergic neurons during subhepatic cholestasis. Neurosci. Behav. Physiol., 38, 807–810.
- Abstract Viewed: 0 times